Kevin R Sayer sold $2.0M of DexCom (DXCM)

Executed Jul 20, disclosed Jul 21, 1 day later.

Value, as filed

$2.0M

26,756 sh × $76.32

Executed

Jul 20

the trade date, as filed

Disclosed

Jul 21

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Kevin R Sayer Executive Chair profile →

Kevin R Sayer (Executive Chair) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in DexCom, Inc. (DXCM). The largest single filing was $2.4M of DXCM (26,659 sh across 2 lots, as filed), executed Aug 20.

The name

DXCM

DexCom, Inc. DXCM · Healthcare · 49 filings in 24 months ticker →

Healthcare · DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) sy…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Kevin R Sayer in DXCM

DXCMSALE DexCom, Inc. $2.4M
26,659 sh across 2 lots
Exec Aug 20
Filed Aug 24 · 4:01 PM ET DXCMSALE DexCom, Inc. $1.9M
26,756 sh × $72.00
Exec Jul 6
Filed Jul 7 · 4:09 PM ET DXCMSALE DexCom, Inc. $1.9M
26,759 sh × $72.00
Exec May 21
Filed May 26 · 5:30 PM ET DXCMSALE DexCom, Inc. $2.3M
32,498 sh × $70.38
Exec Mar 12 2025
Filed Mar 14 2025 · 5:30 PM ET DXCMSALE DexCom, Inc. $2.9M
33,359 sh × $86.91
Exec Jan 29 2025
Filed Jan 30 2025 · 5:30 PM ET